Skip to main content

Clinical trial NIR-DT-301

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients With Progressing Desmoid Tumors (DTs)/Aggressive Fibromatosis (AF)

Cancers
Organ Soft tissue
Trial status Trial closed
Investigator
Trial type
Interventional with experimental drug
Phase Trial phase 3
Academic trial Non
Sponsor SpringWorks Therapeutics
EudraCT Identifier 2018-001991-39
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03785964
Inclusion criteria RECIST v1.1
Last update